Bone Marrow TransplantationTissue DonorsTransplantation, HomologousHistocompatibility TestingGraft vs Host DiseaseHistocompatibilityBone MarrowGraft SurvivalBone Marrow CellsTransplantation ChimeraHematopoietic Stem Cell TransplantationWhole-Body IrradiationTransplantation ConditioningTransplantation, AutologousHematopoietic Stem CellsSurvival AnalysisAnemia, AplasticLeukemiaBone and BonesGraft RejectionRadiation ChimeraLiver TransplantationTransplantation, IsogeneicTransplantation ToleranceGraft Enhancement, ImmunologicKidney TransplantationMice, Inbred C57BLImmunosuppressive AgentsT-LymphocytesLeukocyte TransfusionBusulfanHematopoiesisRecurrenceSkin TransplantationHLA AntigensBone Marrow PurgingImmunosuppressionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTransplantation ImmunologyChimerismTreatment OutcomeLymphocyte DepletionLiving DonorsTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaHeart TransplantationCyclophosphamideDonor SelectionActuarial AnalysisGranulocyte Colony-Stimulating FactorBone Marrow DiseasesHematopoietic Stem Cell MobilizationBlood DonorsHematologic NeoplasmsAcute DiseaseLeukemia, Myeloid, AcuteCombined Modality TherapySpleenChimeraRemission InductionBone Marrow ExaminationLymphocyte Culture Test, MixedLeukemia, MyeloidColony-Forming Units AssayCells, CulturedHepatic Veno-Occlusive DiseaseMice, Inbred BALB CBone RemodelingGraft vs Host ReactionBone Marrow NeoplasmsStem Cell TransplantationLymphoma, Non-HodgkinLymphocyte TransfusionDisease-Free SurvivalCell DifferentiationLymphocytesRetrospective StudiesMyelodysplastic SyndromesSevere Combined ImmunodeficiencyFlow CytometryAntigens, CD34Lung TransplantationHematologic DiseasesCyclosporineMice, Inbred C3HGraft vs Tumor EffectImmune ToleranceBone DensityOrgan TransplantationCarmustineAntineoplastic Combined Chemotherapy ProtocolsSurvival RateNuclear FamilyFollow-Up StudiesGraft vs Leukemia EffectCytomegalovirus InfectionsPancytopeniaLeukocyte CountGranulocytesCytarabine